Table 1.
Overall | SARS-CoV-2 | RSV | Adenovirus | Rhinovirus | Influenza A and B | Metapneumovirus | Coronavirus | |
---|---|---|---|---|---|---|---|---|
n = 767 | n = 408 | n = 204 | n = 56 | n = 32 | n = 44 | n = 17 | n = 6 | |
Socio-demographic characteristics | ||||||||
Age—mo. Median (p25–p75) | 15.77 (3.44–69.80) |
46.46 (7.93–120.98) |
3.25 (1.52–9.33) |
22.31 (12.11–39.54) |
5.77 (1.23–76.70) |
18.59 (4.70–31.05) |
10.03 (6.07–24.69) |
4.93 (1.90–17.41) |
Gender | ||||||||
Female | 345 (44.98) | 182 (44.61) | 95 (46.57) | 27 (48.21) | 12 (37.50) | 21 (47.73) | 6 (35.29) | 2 (3.33) |
Male | 422 (55.02) | 226 (55.39) | 109 (53.43) | 29 (51.79) | 20 (62.50) | 23 (52.27) | 11 (64.71) | 4 (66.67) |
Ethnicity | ||||||||
Caucasian | 597 (77.84) | 316 (77.45) | 151 (74.02) | 47 (83.93) | 28 (87.50) | 39 (88.64) | 13 (76.47) | 3 (50) |
Other | 170 (22.16) | 92 (22.55) | 53 (25.98) | 9 (16.07) | 4 (12.50) | 5 (11.36) | 4 (23.53) | 3 (50) |
Pediatric visit 3 days previous | 151 (19.69) | 15 (3.68) | 75 (36.76) | 20 (35.71) | 11 (34.38) | 17 (38.64) | 8 (47.06) | 5 (83.33) |
Sent by pediatrician | 99 (12.91) | 26 (6.37) | 387 (18.63) | 13 (23.21) | 4 (12.50) | 11 (25) | 6 (35.29) | 1 (16.67) |
Comorbidities | ||||||||
No comorbidities | 546 (71.19) | 293 (71.81) | 145 (71.08) | 38 (67.86) | 21 (65.63) | 32 (72.73) | 12 (70.59) | 5 (83.33) |
At least one comorbidity | 221 (28.8) | 115 (28.19) | 59 (28.9) | 18 (32.14) | 11 (34.38) | 12 (27.27) | 5 (29.41) | 11 (16.67) |
Most frequent comorbidities | ||||||||
Prematurity | 78 (10.17) | 32 (7.84) | 34 (16.67) | 3 (5.36) | 5 (15.63) | 4 (9.09) | 0 (0) | 0 (0) |
Chronic neurologic disease | 22 (2.87) | 9 (2.21) | 5 (2.45) | 4 (7.14) | 3 (9.38) | 0 (0) | 0 (0) | 1 (16.67) |
Onco-hematological disease | 17 (2.22) | 11 (2.70) | 2 (0.98) | 1 (1.79) | 1 (3.13) | 1 (2.27) | 1 (5.88) | 0 (0) |